Stronger, but not (yet) an equal

The use of quality improvement instruments and strategies by patient organisations in the Netherlands

M.G.P. Peeters, D. Delnoij, R.D. Friele

Research output: Contribution to journalArticleScientificpeer-review

Abstract

This article deals with the questions what the benefits and limitations are of the instruments and strategies that patient organisations use to influence quality of care. The advocacy of patients' interests has become more important for patient organisations in recent years, which is partly due to Dutch health care policy reform. Thirty state funded quality improvement projects run by patient organisations between 2009 and 2012 have been analysed. The quality improvement instruments developed and used in these projects are concerned with: standardization and standard setting (What is good care?); consultation, comparison and checking (What is the state of the care given?); and negotiating and advising (How can quality of care be improved?). The choice for these instruments is partly based on patient organisations' strategies of scientization, valuing institutionalized methods and valuing good relationships. We see that the development and use of these quality improvement instruments do strengthen patient organisation and therefore have internal identity and organisational effects. However, the external effects patient organisations can have by using these instruments and strategies is limited or at least insecure by lack of economic capital after the development phase and lack of negotiating power. The external effects of these instruments and strategies depend largely on a patient organisation's network and the willingness, degree of openness and policy of other stakeholders to cooperate. Therefore, these forms of patient participation remain vulnerable.
Original languageEnglish
Pages (from-to)56-63
JournalSocial Science & Medicine
Volume115
DOIs
Publication statusPublished - Aug 2014

Keywords

  • Patient participation
  • Patient organisations
  • Third party
  • Regulated competition
  • Quality improvement
  • Neo-corporatism
  • The Netherlands

Cite this

@article{9173147141ac4012918ed92697b1046e,
title = "Stronger, but not (yet) an equal: The use of quality improvement instruments and strategies by patient organisations in the Netherlands",
abstract = "This article deals with the questions what the benefits and limitations are of the instruments and strategies that patient organisations use to influence quality of care. The advocacy of patients' interests has become more important for patient organisations in recent years, which is partly due to Dutch health care policy reform. Thirty state funded quality improvement projects run by patient organisations between 2009 and 2012 have been analysed. The quality improvement instruments developed and used in these projects are concerned with: standardization and standard setting (What is good care?); consultation, comparison and checking (What is the state of the care given?); and negotiating and advising (How can quality of care be improved?). The choice for these instruments is partly based on patient organisations' strategies of scientization, valuing institutionalized methods and valuing good relationships. We see that the development and use of these quality improvement instruments do strengthen patient organisation and therefore have internal identity and organisational effects. However, the external effects patient organisations can have by using these instruments and strategies is limited or at least insecure by lack of economic capital after the development phase and lack of negotiating power. The external effects of these instruments and strategies depend largely on a patient organisation's network and the willingness, degree of openness and policy of other stakeholders to cooperate. Therefore, these forms of patient participation remain vulnerable.",
keywords = "Patient participation, Patient organisations, Third party, Regulated competition, Quality improvement, Neo-corporatism, The Netherlands",
author = "M.G.P. Peeters and D. Delnoij and R.D. Friele",
year = "2014",
month = "8",
doi = "10.1016/j.socscimed.2014.05.043",
language = "English",
volume = "115",
pages = "56--63",
journal = "Social Science & Medicine",
issn = "0277-9536",
publisher = "PERGAMON-ELSEVIER SCIENCE LTD",

}

Stronger, but not (yet) an equal : The use of quality improvement instruments and strategies by patient organisations in the Netherlands. / Peeters, M.G.P.; Delnoij, D. ; Friele, R.D.

In: Social Science & Medicine, Vol. 115, 08.2014, p. 56-63.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Stronger, but not (yet) an equal

T2 - The use of quality improvement instruments and strategies by patient organisations in the Netherlands

AU - Peeters, M.G.P.

AU - Delnoij, D.

AU - Friele, R.D.

PY - 2014/8

Y1 - 2014/8

N2 - This article deals with the questions what the benefits and limitations are of the instruments and strategies that patient organisations use to influence quality of care. The advocacy of patients' interests has become more important for patient organisations in recent years, which is partly due to Dutch health care policy reform. Thirty state funded quality improvement projects run by patient organisations between 2009 and 2012 have been analysed. The quality improvement instruments developed and used in these projects are concerned with: standardization and standard setting (What is good care?); consultation, comparison and checking (What is the state of the care given?); and negotiating and advising (How can quality of care be improved?). The choice for these instruments is partly based on patient organisations' strategies of scientization, valuing institutionalized methods and valuing good relationships. We see that the development and use of these quality improvement instruments do strengthen patient organisation and therefore have internal identity and organisational effects. However, the external effects patient organisations can have by using these instruments and strategies is limited or at least insecure by lack of economic capital after the development phase and lack of negotiating power. The external effects of these instruments and strategies depend largely on a patient organisation's network and the willingness, degree of openness and policy of other stakeholders to cooperate. Therefore, these forms of patient participation remain vulnerable.

AB - This article deals with the questions what the benefits and limitations are of the instruments and strategies that patient organisations use to influence quality of care. The advocacy of patients' interests has become more important for patient organisations in recent years, which is partly due to Dutch health care policy reform. Thirty state funded quality improvement projects run by patient organisations between 2009 and 2012 have been analysed. The quality improvement instruments developed and used in these projects are concerned with: standardization and standard setting (What is good care?); consultation, comparison and checking (What is the state of the care given?); and negotiating and advising (How can quality of care be improved?). The choice for these instruments is partly based on patient organisations' strategies of scientization, valuing institutionalized methods and valuing good relationships. We see that the development and use of these quality improvement instruments do strengthen patient organisation and therefore have internal identity and organisational effects. However, the external effects patient organisations can have by using these instruments and strategies is limited or at least insecure by lack of economic capital after the development phase and lack of negotiating power. The external effects of these instruments and strategies depend largely on a patient organisation's network and the willingness, degree of openness and policy of other stakeholders to cooperate. Therefore, these forms of patient participation remain vulnerable.

KW - Patient participation

KW - Patient organisations

KW - Third party

KW - Regulated competition

KW - Quality improvement

KW - Neo-corporatism

KW - The Netherlands

U2 - 10.1016/j.socscimed.2014.05.043

DO - 10.1016/j.socscimed.2014.05.043

M3 - Article

VL - 115

SP - 56

EP - 63

JO - Social Science & Medicine

JF - Social Science & Medicine

SN - 0277-9536

ER -